All In Biotech

Free tool

FAERS Monitor: Isordil

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 012093 or its brand name (Isordil, Isosorbide Dinitrate). Reports on generic versions are filed under their own applications.

Reports

8,622

Serious

7,030

82% of reports

Hospitalization

4,081

Death reported

1,283

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea931
  • nausea829
  • diarrhoea789
  • fatigue774
  • dizziness762
  • vomiting690
  • chest pain687
  • pain642
  • myocardial infarction641
  • headache636
  • malaise608
  • pyrexia597
  • pruritus571
  • anxiety550
  • arthralgia540

Reports by year received

View as table
YearReports
2004271
2005273
2006249
2007289
2008370
2009259
2010317
2011738
2012532
2013227
2014298
2015298
2016338
2017387
2018441
2019420
2020409
2021389
2022353
2023629
2024399
2025458
2026276

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,537 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chest painSignal6879.18.44,956
myocardial infarctionSignal6419.08.34,566
anxietySignal5504.74.41,629
pyrexiaSignal5974.23.91,482
dyspnoeaSignal9314.03.82,161
dizzinessSignal7623.73.51,555
pruritusSignal5713.63.41,103
vomitingSignal6903.63.31,310
malaiseSignal6083.43.11,040
arthralgiaSignal5403.22.9816
diarrhoeaSignal7893.02.81,071
nauseaSignal8292.62.4814
painSignal6422.62.4621
headacheSignal6362.52.3575
fatigueSignal7742.42.3672

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.